• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性唇炎和口腔鳞状细胞癌患者中程序性死亡受体 1(PD-1)和 PD-1 配体(PD-L1)表达增强。

Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma.

机构信息

Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Octávio Pinheiro Brisolla 9-75, Bauru, SP, Brazil.

出版信息

Cancer Immunol Immunother. 2011 Jul;60(7):965-74. doi: 10.1007/s00262-011-1007-5. Epub 2011 Mar 27.

DOI:10.1007/s00262-011-1007-5
PMID:21442435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11028705/
Abstract

PD-1 and PD-L1 can be involved in tumor escape, and little is known about the role of these molecules in oral tumors or pre-malignant lesions. In the present study, we investigated the expression of PD-1 and PD-L1 in the blood and lesion samples of patients with actinic cheilitis (AC) and oral squamous cell carcinoma (OSCC). Our results showed that lymphocytes from peripheral blood and tissue samples exhibited high expression of PD-1 in both groups analyzed. Patients with AC presented higher percentage as well as the absolute numbers of CD4+PD-1+ and CD8+PD-1+ lymphocytes in peripheral blood mononuclear cells (PBMC) than healthy individuals, while patients with OSCC presented an increased frequency of CD8+PD1+ in PBMC when compared with controls. On the other hand, increased frequency of CD4+ and CD8+ T cells expressing PD-1(+) accumulate in samples from OSCC, and the expression of PD-L1 was intense in OSCC and moderate in AC lesion sites. Lower levels of IFN-γ and higher levels of TGF-β were detected in OSCC samples. Our data demonstrate that PD-1 and PD-L1 molecules are present in blood and samples of AC and OSCC patients. Further studies are required to understand the significance of PD-1 and PD-L1 in oral tumors microenvironment.

摘要

PD-1 和 PD-L1 可参与肿瘤逃逸,而这些分子在口腔肿瘤或癌前病变中的作用知之甚少。在本研究中,我们研究了 PD-1 和 PD-L1 在光化性唇炎 (AC) 和口腔鳞状细胞癌 (OSCC) 患者的血液和病变样本中的表达。结果显示,两组患者外周血和组织样本中的淋巴细胞均高表达 PD-1。AC 患者外周血单个核细胞 (PBMC) 中 CD4+PD-1+和 CD8+PD-1+淋巴细胞的百分比和绝对数均高于健康个体,而 OSCC 患者 PBMC 中 CD8+PD1+的频率高于对照组。另一方面,表达 PD-1(+)的 CD4+和 CD8+T 细胞在 OSCC 样本中积累增多,PD-L1 在 OSCC 中表达强烈,在 AC 病变部位中度表达。OSCC 样本中检测到 IFN-γ 水平降低和 TGF-β 水平升高。本研究数据表明,PD-1 和 PD-L1 分子存在于 AC 和 OSCC 患者的血液和样本中。需要进一步研究以了解 PD-1 和 PD-L1 在口腔肿瘤微环境中的意义。

相似文献

1
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma.光化性唇炎和口腔鳞状细胞癌患者中程序性死亡受体 1(PD-1)和 PD-1 配体(PD-L1)表达增强。
Cancer Immunol Immunother. 2011 Jul;60(7):965-74. doi: 10.1007/s00262-011-1007-5. Epub 2011 Mar 27.
2
Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.日光性唇炎和下唇鳞状细胞癌微环境中 PD-L1、CD4+ 和 CD8+ 细胞浸润及肿瘤浸润淋巴细胞(TILs)的免疫表达。
J Appl Oral Sci. 2022 Feb 21;30:e20210344. doi: 10.1590/1678-7757-2021-0344. eCollection 2022.
3
[Levels of programmed death-1 and programmed death ligand-1 in the peripheral blood of patients with oral squamous cell carcinoma and its clinical implications].[口腔鳞状细胞癌患者外周血中程序性死亡蛋白-1和程序性死亡配体-1水平及其临床意义]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2015 Oct;33(5):529-33. doi: 10.7518/hxkq.2015.05.019.
4
Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.免疫调节分子 PD-L1 和 PD-1 在口腔癌及癌前病变中的表达:一项日本患者的队列研究。
J Craniomaxillofac Surg. 2019 Jan;47(1):33-40. doi: 10.1016/j.jcms.2017.04.013. Epub 2017 May 10.
5
Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.程序性细胞死亡配体 1 在口腔鳞状细胞癌和口腔白斑病中的表达与疾病进展和 CD8+肿瘤浸润淋巴细胞有关。
Pathol Res Pract. 2019 Jun;215(6):152418. doi: 10.1016/j.prp.2019.04.010. Epub 2019 Apr 18.
6
Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.程序性死亡受体-1 及其配体程序性死亡配体-1 在有和无口腔黏膜下纤维性变的口腔鳞状细胞癌中的差异表达。
Arch Oral Biol. 2020 Nov;119:104916. doi: 10.1016/j.archoralbio.2020.104916. Epub 2020 Sep 17.
7
Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 with CD8/PD-1.口腔鳞状细胞癌中有利预后亚群的鉴定:ITGB4/PD-L1 与 CD8/PD-1 的特征。
Biomolecules. 2023 Jun 19;13(6):1014. doi: 10.3390/biom13061014.
8
Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.PD-L2 表达在口腔鳞状细胞癌患者中的预后意义-与 PD-L1 表达谱的比较。
Cancer Med. 2019 Mar;8(3):1124-1134. doi: 10.1002/cam4.1929. Epub 2019 Jan 18.
9
CD163CD204 tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma.CD163CD204 肿瘤相关巨噬细胞通过产生白细胞介素-10 和 PD-L1 促进口腔鳞状细胞癌中的 T 细胞调节。
Sci Rep. 2017 May 11;7(1):1755. doi: 10.1038/s41598-017-01661-z.
10
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4 TILs in the Presence of PD-L1 TAMs.头颈部鳞状细胞癌中PD-1的表达主要源于在存在PD-L1肿瘤相关巨噬细胞的情况下功能失能的CD4肿瘤浸润淋巴细胞。
Cancer Res. 2017 Nov 15;77(22):6365-6374. doi: 10.1158/0008-5472.CAN-16-3453. Epub 2017 Sep 25.

引用本文的文献

1
Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease.外周血T细胞亚群上PD-1的上调与帕金森病相关。
Mol Neurobiol. 2025 Jun 19. doi: 10.1007/s12035-025-05153-4.
2
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study.病例报告:通过酶联免疫吸附测定法进行非侵入性细胞唾液采样和生物标志物检测与组织病理学诊断口腔潜在恶性疾病的比较——一项病例对照研究的见解
Front Immunol. 2024 Nov 29;15:1477477. doi: 10.3389/fimmu.2024.1477477. eCollection 2024.
3
Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics.免疫疗法:口腔癌治疗的第四个领域。
Indian J Otolaryngol Head Neck Surg. 2024 Jun;76(3):2257-2272. doi: 10.1007/s12070-024-04565-3. Epub 2024 Mar 10.
4
Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods.口腔鳞状细胞癌及PD-1/PD-L1相关免疫治疗方法的分子基础、潜在生物标志物及未来前景
Heliyon. 2024 Feb 10;10(4):e25895. doi: 10.1016/j.heliyon.2024.e25895. eCollection 2024 Feb 29.
5
Expression of PD-L1 and p-RPS6 in epithelial dysplasia and squamous cell carcinoma of the oral cavity.口腔上皮发育异常和鳞状细胞癌中PD-L1和p-RPS6的表达
Front Oral Health. 2024 Feb 2;5:1337582. doi: 10.3389/froh.2024.1337582. eCollection 2024.
6
Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small-Molecule PD-L1 Blockade.局部小分子程序性死亡配体1(PD-L1)阻断对SKH-1小鼠皮肤紫外线诱导的应激信号和炎症反应的抑制作用
JID Innov. 2024 Jan 5;4(2):100255. doi: 10.1016/j.xjidi.2023.100255. eCollection 2024 Mar.
7
Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.口腔白斑病和口腔鳞状细胞癌中 PD-1 和 PD-L1 表达的相关性:一项免疫组织化学研究。
Sci Rep. 2023 Dec 7;13(1):21698. doi: 10.1038/s41598-023-48572-w.
8
Expression characteristics of peripheral lymphocyte programmed death 1 and FoxP3 Tregs in gastric cancer during surgery and chemotherapy.手术和化疗期间胃癌患者外周血淋巴细胞程序性死亡 1 及 FoxP3+Tregs 的表达特征。
World J Gastroenterol. 2023 Oct 28;29(40):5582-5592. doi: 10.3748/wjg.v29.i40.5582.
9
Precancerous Lesions of the Head and Neck Region and Their Stromal Aberrations: Piecemeal Data.头颈部区域的癌前病变及其基质异常:零散数据。
Cancers (Basel). 2023 Apr 7;15(8):2192. doi: 10.3390/cancers15082192.
10
Predicting postoperative gastric cancer prognosis based on inflammatory factors and machine learning technology.基于炎症因子和机器学习技术预测胃癌术后预后。
BMC Med Inform Decis Mak. 2023 Mar 31;23(1):53. doi: 10.1186/s12911-023-02150-2.

本文引用的文献

1
Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.免疫检查点蛋白:癌症治疗的新范例——临床前背景:CTLA-4 和 PD-1 阻断。
Semin Oncol. 2010 Oct;37(5):430-9. doi: 10.1053/j.seminoncol.2010.09.005.
2
The dynamic roles of TGF-β in cancer.TGF-β 在癌症中的动态作用。
J Pathol. 2011 Jan;223(2):205-18. doi: 10.1002/path.2785. Epub 2010 Oct 18.
3
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation.组织浸润淋巴细胞:细胞因子在其生长和分化中的作用
J Biol Regul Homeost Agents. 2010 Jul-Sep;24(3):239-49.
4
Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer.细胞增殖、凋亡和血管生成:营养预防癌症的分子靶点。
Semin Oncol. 2010 Jun;37(3):243-57. doi: 10.1053/j.seminoncol.2010.05.001.
5
TGFβ signaling in head and neck squamous cell carcinoma.TGFβ 信号通路在头颈部鳞状细胞癌中的作用。
Oncogene. 2010 Oct 7;29(40):5437-46. doi: 10.1038/onc.2010.306. Epub 2010 Aug 2.
6
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.IAPs:从细胞胱冬酶抑制剂到 NF-κB、炎症和癌症的调节剂。
Nat Rev Cancer. 2010 Aug;10(8):561-74. doi: 10.1038/nrc2889.
7
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.CD4+ 细胞毒性 T 淋巴细胞在控制病毒疾病和癌症中的作用。
Int Rev Immunol. 2010 Aug;29(4):371-402. doi: 10.3109/08830185.2010.489658.
8
The polarization of immune cells in the tumour environment by TGFbeta.肿瘤微环境中 TGFβ对免疫细胞的极化作用。
Nat Rev Immunol. 2010 Aug;10(8):554-67. doi: 10.1038/nri2808. Epub 2010 Jul 9.
9
White oral lesions, actinic cheilitis, and leukoplakia: confusions in terminology and definition: facts and controversies.白色口腔损害、光化性唇炎和口腔白斑:术语和定义上的混淆:事实与争议。
Clin Dermatol. 2010 May-Jun;28(3):262-8. doi: 10.1016/j.clindermatol.2009.06.011.
10
Cancer inflammation and regulatory T cells.癌症炎症与调节性 T 细胞。
Int J Cancer. 2010 Aug 15;127(4):768-79. doi: 10.1002/ijc.25430.